To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANKRA2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
201 supporting clones for gene ANKRA2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL558295 T cells from T cell leukemia .a 1 to 946 1 to 939   tiling clone,   939/939
(100 %)
14 diff
(98.6 %id)
AL706363 human skeletal muscle .a 7 to 221 1 to 211       211/211
(100 %)
13 diff
(93.9 %id)
AL697755 human skeletal muscle .a 8 to 578 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
BX399687 Placenta Cot 25-normalized .a 9 to 1064 1 to 1046   fully sequenced,   1046/1046
(100 %)
22 diff
(97.9 %id)
DB474550 hippocampus .a 9 to 502 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
DB480704 hippocampus .a 9 to 507 1 to 499       499/501
(99 %)
2 diff
(99.7 %id)
AF251051   .a 13 to 2060 1 to 2048 exact     2048/2048
(100 %)
2 diff
(100.0 %id)
TI_45214368   .a 14 to 784 86 to 857       767/858
(89 %)
12 diff
(98.7 %id)
NM_023039.3   .a 14 to 2060 1 to 2047 exact RefSeq,   2047/2047
(100 %)
1 diff
(100.0 %id)
CF593591 Human Placenta, placenta .a 15 to 827 22 to 841       815/844
(96 %)
15 diff
(98.3 %id)
BI602969 brain, hypothalamus .a 16 to 784 1 to 775       770/776
(99 %)
9 diff
(98.9 %id)
DB445954 testis .a 19 to 484 1 to 466       466/466
(100 %)
5 diff
(99.0 %id)
AL536730 brain, fetal brain .a 20 to 894 1 to 873       873/873
(100 %)
7 diff
(99.2 %id)
BX445186 brain, fetal brain .a 20 to 1040 1 to 1019       1019/1037
(98 %)
23 diff
(97.8 %id)
CX754290 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 20 to 736 34 to 750     Submitted on the opposite strand 712/750
(94 %)
8 diff
(99.0 %id)
DB481204 hippocampus .a 22 to 462 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
CV803625 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 26 to 728 1 to 693       693/844
(82 %)
12 diff
(98.6 %id)
BX405620 fetal liver, Liver .a 28 to 948 1 to 919       919/919
(100 %)
25 diff
(97.3 %id)
EC535484 Prostate .a 29 to 139 1 to 110       110/112
(98 %)
4 diff
(96.5 %id)
TI_57181514   .a 31 to 784 29 to 781       753/781
(96 %)
13 diff
(98.4 %id)
BE874503 large cell carcinoma, undifferentiated, lung .a 33 to 798 1 to 755       755/961
(78 %)
20 diff
(98.0 %id)
BI768852 pooled lung and spleen .a 37 to 784 1 to 747       747/747
(100 %)
8 diff
(99.0 %id)
BI224522 cervical carcinoma cell line, cervix .a 38 to 731 37 to 728       687/728
(94 %)
7 diff
(99.1 %id)
DB489835 hypothalamus .a 44 to 488 1 to 442       442/442
(100 %)
10 diff
(97.8 %id)
BI601930 brain, hypothalamus .a 44 to 807 1 to 773       768/774
(99 %)
14 diff
(98.2 %id)
BM466702 eye, retinoblastoma .a 44 to 851 1 to 810       810/1072
(75 %)
18 diff
(98.4 %id)
TI_45209673   .a 45 to 807 129 to 895       762/896
(85 %)
14 diff
(98.5 %id)
DR760917 embryonic stem .a 49 to 855 1 to 807       807/807
(100 %)
0 diff
(100 %id)
AL546663.
matches multiple genes
placenta, Placenta Cot 25-normalized .a 54 to 1036 1 to 979   fully sequenced, also hits gene INTS4 979/979
(100 %)
7 diff
(99.3 %id)
CN310758 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 62 to 620 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
BI761919 pooled colon, kidney, stomach .a 63 to 854 1 to 799       799/964
(82 %)
16 diff
(98.4 %id)
TI_57150975   .a 63 to 854 36 to 834       794/999
(79 %)
22 diff
(97.8 %id)
CR600986 Placenta Cot 25-normalized .a 69 to 2032 1 to 1964 exact tiling clone,   1964/1964
(100 %)
0 diff
(100 %id)
BX339562 Placenta Cot 25-normalized .a 69 to 1067 1 to 986   fully sequenced,   986/986
(100 %)
6 diff
(99.4 %id)
BF680281 Prostate .a 69 to 750 1 to 681       681/897
(75 %)
12 diff
(98.7 %id)
AL709995 human skeletal muscle .a 70 to 799 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
DA040375 bladder .a 71 to 646 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
BE785353 large cell carcinoma, lung .a 84 to 801 1 to 711       711/927
(76 %)
37 diff
(96.1 %id)
DA825544 pericardium .a 84 to 624 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
BE242684 leukopheresis .a 93 to 447 1 to 355       355/355
(100 %)
5 diff
(98.6 %id)
BG741974 skin .a 94 to 1001 1 to 922       838/922
(90 %)
37 diff
(96.0 %id)
CN310760 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 106 to 727 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
AA206737   .a 116 to 479 1 to 367       367/367
(100 %)
10 diff
(97.3 %id)
BC012917 Kidney, hypernephroma .a 135 to 2062 1 to 1928 exact available from MGC, AAA   1928/1928
(100 %)
1 diff
(100.0 %id)
BG168447 hypernephroma, cell line, Kidney .a 135 to 904 1 to 781       781/896
(87 %)
28 diff
(96.9 %id)
BG708465 brain, hypothalamus .a 137 to 845 1 to 721       716/721
(99 %)
15 diff
(98.0 %id)
DB488303 hypothalamus .a 141 to 555 1 to 415       415/442
(93 %)
6 diff
(98.7 %id)
DB498129 hypothalamus .a 141 to 632 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
CN310762 embryonic stem cells, DMSO-treated H9 cellline .a 179 to 482 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BM686838.
matches multiple genes
eye, eye anterior segment .a 182 to 748 1 to 572     also hits gene DCAKD 572/572
(100 %)
3 diff
(99.5 %id)
AA249198   .a 184 to 318 1 to 134       134/140
(95 %)
3 diff
(97.9 %id)
BM701933 eye, optic nerve .a 184 to 880 9 to 704       696/696
(100 %)
1 diff
(99.9 %id)
AA249010   .a 196 to 454 1 to 257       257/260
(98 %)
15 diff
(94.3 %id)
BX364905 Placenta Cot 25-normalized .a 218 to 1072 181 to 1035       984/1040
(94 %)
66 diff
(93.7 %id)
AK022876   .a 254 to 2062 1 to 1809 exact available from FLJ,   1809/1809
(100 %)
1 diff
(100.0 %id)
AU128002   .a 255 to 917 2 to 665   capped   664/666
(99 %)
6 diff
(99.1 %id)
N34064.
matches multiple genes
melanocyte .a 260 to 766 1 to 516     also hits gene RPS23 516/521
(99 %)
15 diff
(97.2 %id)
BG700360 brain, hippocampus .a 266 to 784 1 to 538       533/539
(98 %)
29 diff
(94.7 %id)
DB242604 stomach, tumor tissue .a 269 to 796 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
DB243631 stomach, tumor tissue .a 269 to 828 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
CN310763 embryonic stem cells, cell lines H1, H7, andH9 .a 270 to 435 1 to 166       166/166
(100 %)
1 diff
(99.4 %id)
BX363000   .a 277 to 1106 1 to 828       828/848
(97 %)
10 diff
(98.9 %id)
BG699566 brain, hippocampus .a 277 to 851 1 to 581       576/581
(99 %)
11 diff
(98.2 %id)
CD698435 normal nasopharynx .a 279 to 372 5 to 100       96/100
(96 %)
9 diff
(91.0 %id)
DB475859.
matches multiple genes
hippocampus .a 284 to 763 1 to 485     also hits gene klypleyby 480/485
(98 %)
1 diff
(99.8 %id)
TI_57234602   .a 284 to 1118 32 to 867       836/867
(96 %)
13 diff
(98.6 %id)
BI908680 leukocyte .a 292 to 1118 1 to 827       827/827
(100 %)
8 diff
(99.1 %id)
BI602301 brain, hypothalamus .a 295 to 1107 1 to 811       811/825
(98 %)
11 diff
(98.7 %id)
TI_45213875   .a 299 to 1107 125 to 931       807/945
(85 %)
13 diff
(98.7 %id)
BI909108 leukocyte .a 303 to 1106 1 to 814       814/827
(98 %)
27 diff
(96.8 %id)
TI_57237342   .a 303 to 1106 28 to 841       814/854
(95 %)
26 diff
(97.0 %id)
BI669422 brain, hypothalamus .a 306 to 1035 1 to 736       736/737
(99 %)
23 diff
(96.9 %id)
TI_44344957   .a 311 to 1035 154 to 884       731/885
(82 %)
23 diff
(97.5 %id)
BG114727 duodenal adenocarcinoma, cell line, small intestine .a 312 to 1027 1 to 711       711/964
(73 %)
15 diff
(98.5 %id)
TI_57164450   .a 312 to 1104 66 to 890       820/909
(90 %)
41 diff
(95.5 %id)
BI833976 pooled pancreas and spleen .a 315 to 1104 1 to 825       820/844
(97 %)
42 diff
(95.1 %id)
BX387999   .a 316 to 1150 1 to 834       834/834
(100 %)
7 diff
(99.2 %id)
CN310766 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 329 to 1068 1 to 740       740/740
(100 %)
0 diff
(100 %id)
BI549092 brain, hippocampus .a 362 to 505 358 to 510       486/510
(95 %)
35 diff
(93.2 %id)
AF314032   .a 581 to 2062 1 to 1482 exact AAA   1482/1482
(100 %)
2 diff
(99.9 %id)
AW079850 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 581 to 993 1 to 414     Submitted on the opposite strand 414/415
(99 %)
4 diff
(99.1 %id)
BX390826   .a 612 to 1462 1 to 848       848/929
(91 %)
23 diff
(97.6 %id)
CV023980 mixed .a 660 to 1178 1 to 518       518/522
(99 %)
4 diff
(99.3 %id)
BP424592 small intestine .a 682 to 1173 1 to 492     Submitted on the opposite strand 492/500
(98 %)
3 diff
(99.4 %id)
CX867100 embryonic stem .a 776 to 1181 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
EL954879 eyeball .a 820 to 1049 43 to 276       234/276
(84 %)
10 diff
(96.4 %id)
BX405619 fetal liver, Liver .a 960 to 2051 1090 to 1       949/1093
(86 %)
58 diff
(94.7 %id)
BM711293 eye, fetal eyes .a 974 to 1514 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AL571924.
matches multiple genes
placenta, Placenta Cot 25-normalized .a 1006 to 2046 1031 to 1   fully sequenced, also hits gene INTS4 1031/1031
(100 %)
22 diff
(97.9 %id)
BX399686 Placenta Cot 25-normalized .a 1034 to 2049 1015 to 1   fully sequenced,   983/983
(100 %)
43 diff
(95.7 %id)
BX339561 Placenta Cot 25-normalized .a 1037 to 2032 988 to 1   fully sequenced,   986/986
(100 %)
9 diff
(99.1 %id)
AA418089 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1069 to 1415 1 to 347       347/347
(100 %)
2 diff
(99.5 %id)
TI_149302874   .a 1162 to 2062 962 to 70   AAA   893/959
(93 %)
15 diff
(98.5 %id)
BX106300   .a 1164 to 1554 1 to 391       391/392
(99 %)
2 diff
(99.5 %id)
AA442702   .a 1164 to 1593 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BX387998   .a 1172 to 2046 876 to 1       876/876
(100 %)
11 diff
(98.8 %id)
BF884881 lung_tumor .a 1272 to 1696 455 to 30     Submitted on the opposite strand 426/455
(93 %)
1 diff
(99.8 %id)
FN092225 breast carcinoma .a 1292 to 1366 1 to 75       75/75
(100 %)
2 diff
(97.4 %id)
BM980992 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1299 to 2062 782 to 19   AAA   764/764
(100 %)
1 diff
(99.9 %id)
BU633818 cell lines, Chondrosarcoma .a 1301 to 2062 780 to 19   AAA   762/762
(100 %)
3 diff
(99.7 %id)
AI829903 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1323 to 2063 741 to 1       741/741
(100 %)
8 diff
(99.0 %id)
BF969470 adrenal cortex carcinoma, cell line, adrenal gland .a 1330 to 1739 1 to 409   AAA   409/409
(100 %)
1 diff
(99.8 %id)
FN078781 breast carcinoma .a 1354 to 1422 69 to 1     Submitted on the opposite strand 69/76
(90 %)
0 diff
(100 %id)
BM671082 eye, optic nerve .a 1366 to 2062 715 to 19   AAA   697/697
(100 %)
1 diff
(99.9 %id)
TI_149303026   .a 1369 to 2065 309 to 1002     Submitted on the opposite strand 694/1046
(66 %)
21 diff
(98.0 %id)
TI_154105085   .a 1379 to 2062 769 to 87   AAA   683/684
(99 %)
2 diff
(99.8 %id)
AI984540 malignant melanoma, metastatic to lymphnode, skin .a 1397 to 2036 639 to 1       639/662
(96 %)
18 diff
(97.3 %id)
TI_154000624   .a 1397 to 2062 769 to 105   AAA   665/966
(68 %)
36 diff
(96.3 %id)
BM981115 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1397 to 1841 268 to 712     Submitted on the opposite strand 445/466
(95 %)
10 diff
(97.9 %id)
AI769747 2 pooled tumors (clear cell type), Kidney .a 1398 to 2063 669 to 3       667/669
(99 %)
13 diff
(98.1 %id)
CA446373 Chondrosarcoma, Left Pubic Bone .a 1399 to 2062 681 to 19   AAA   663/663
(100 %)
2 diff
(99.7 %id)
AI633646 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1410 to 2062 664 to 12   AAA   653/653
(100 %)
3 diff
(99.6 %id)
BG055419 carcinoid, lung .a 1420 to 2063 647 to 3       645/647
(99 %)
9 diff
(98.7 %id)
BQ425022 melanotic melanoma, skin .a 1442 to 2060 1 to 622       622/917
(67 %)
7 diff
(99.3 %id)
AW518841 adenocarcinoma, Pancreas .a 1443 to 2063 623 to 3       621/623
(99 %)
1 diff
(99.9 %id)
AW337994 adenocarcinoma, Pancreas .a 1449 to 2062 626 to 12   AAA   615/615
(100 %)
3 diff
(99.6 %id)
CN310761 embryonic stem cells, DMSO-treated H9 cellline .a 1455 to 2059 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BM666282 eye, fetal eyes .a 1517 to 2062 564 to 19   AAA   546/546
(100 %)
2 diff
(99.7 %id)
BX342243   .a 1545 to 2006 469 to 1       469/469
(100 %)
8 diff
(98.3 %id)
AV747168 Pituitary .a 1545 to 1997 442 to 1     Submitted on the opposite strand 442/542
(81 %)
12 diff
(97.8 %id)
AU150348   .a 1545 to 2062 518 to 1       518/576
(89 %)
7 diff
(98.8 %id)
AW771301 Kidney .a 1551 to 1672 122 to 1       122/122
(100 %)
0 diff
(100 %id)
AA205305   .a 1556 to 2063 510 to 1       510/510
(100 %)
9 diff
(98.3 %id)
BE674641 carcinoid, lung .a 1578 to 2063 488 to 3       486/488
(99 %)
0 diff
(100 %id)
AI354761 lung .a 1580 to 2058 482 to 4       479/482
(99 %)
0 diff
(100 %id)
DB550021 hippocampus .a 1584 to 2060 1 to 477     Submitted on the opposite strand 477/479
(99 %)
1 diff
(99.8 %id)
AI696473 carcinoid, lung .a 1587 to 2061 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
DB569222 hypothalamus .a 1603 to 2062 1 to 460     Submitted on the opposite strand 460/460
(100 %)
1 diff
(99.8 %id)
TI_154002312   .a 1618 to 2062 562 to 118   AAA   445/445
(100 %)
1 diff
(99.8 %id)
AW014492   .a 1619 to 2062 461 to 18   AAA   444/444
(100 %)
1 diff
(99.8 %id)
DB549472 hippocampus .a 1620 to 2062 1 to 443     Submitted on the opposite strand 443/444
(99 %)
1 diff
(99.8 %id)
DB526882 testis .a 1638 to 2062 1 to 430   AAA Submitted on the opposite strand 430/430
(100 %)
20 diff
(95.4 %id)
CA433288 mixed .a 1639 to 2062 442 to 19   AAA   424/424
(100 %)
1 diff
(99.8 %id)
AV747886 Pituitary .a 1641 to 2059 417 to 1     Submitted on the opposite strand 417/443
(94 %)
4 diff
(99.1 %id)
AA418029 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1646 to 2062 417 to 1     Submitted on the opposite strand 417/417
(100 %)
1 diff
(99.8 %id)
AA811626 germinal center B cell .a 1646 to 2062 427 to 11   AAA   417/417
(100 %)
1 diff
(99.8 %id)
DB559583 hypothalamus .a 1658 to 2062 1 to 405     Submitted on the opposite strand 405/405
(100 %)
8 diff
(98.1 %id)
BX436217.
matches multiple genes
fetal liver, Liver .a 1664 to 2049 382 to 1     also hits gene GPR160 382/469
(81 %)
24 diff
(94.9 %id)
N70046 lung .a 1666 to 2062 405 to 1       405/411
(98 %)
12 diff
(97.1 %id)
AA808125 germinal center B cell .a 1667 to 2063 405 to 9       397/405
(98 %)
0 diff
(100 %id)
AA633452 breast .a 1668 to 1917 250 to 1       250/250
(100 %)
2 diff
(99.2 %id)
AI825035 pooled germ cell tumors .a 1677 to 2062 392 to 1       392/574
(68 %)
11 diff
(98.1 %id)
AW589703 pooled germ cell tumors .a 1705 to 2062 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
DB543368 hippocampus .a 1721 to 2198 1 to 478     Submitted on the opposite strand 478/478
(100 %)
1 diff
(99.8 %id)
AI371756 pooled germ cell tumors .a 1732 to 2198 467 to 1   tiling clone,   467/467
(100 %)
0 diff
(100 %id)
AW302373 brain, three pooled meningiomas .a 1734 to 2058 333 to 9       325/333
(97 %)
0 diff
(100 %id)
N25678.
matches multiple genes
melanocyte .a 1736 to 2062 327 to 1     also hits gene FKBP11 327/327
(100 %)
2 diff
(99.4 %id)
DB511004 testis .a 1744 to 2062 1 to 319   AAA Submitted on the opposite strand 319/319
(100 %)
9 diff
(97.2 %id)
AI915190 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1746 to 2063 322 to 5       318/322
(98 %)
0 diff
(100 %id)
AW770054 lymph node, lymphoma, follicular mixed small and largecell .a 1752 to 2063 312 to 1       312/312
(100 %)
0 diff
(100 %id)
DB537589 hippocampus .a 1765 to 2198 1 to 435     Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
AA810844 germinal center B cell .a 1774 to 2062 311 to 23   AAA   289/289
(100 %)
1 diff
(99.7 %id)
AA846497 parathyroid gland, parathyroid tumor .a 1777 to 2062 301 to 16   AAA   286/286
(100 %)
1 diff
(99.7 %id)
AI299340 carcinoid, lung .a 1796 to 2062 286 to 20   AAA   267/267
(100 %)
7 diff
(97.4 %id)
AI916429 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1796 to 2071 307 to 32   AAA   276/276
(100 %)
4 diff
(98.6 %id)
AA496038   .a 1848 to 2063 221 to 6       216/221
(97 %)
0 diff
(100 %id)
BQ222914 melanotic melanoma, skin .b 1 to 902 1 to 901   tiling clone,   901/901
(100 %)
2 diff
(99.8 %id)
BG259048 embryonal carcinoma, cell line, testis .b 725 to 1478 1 to 774   tiling clone,   774/891
(86 %)
22 diff
(97.6 %id)
AI986119 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 919 to 1606 689 to 1   tiling clone,   689/689
(100 %)
13 diff
(98.2 %id)
TI_57178519   .c-u 1 to 636 36 to 671 F138S I139H A140S P141T S142F ...     642/671
(95 %)
6 diff
(99.2 %id)
BI769165 pooled lung and spleen .c-u 1 to 636 4 to 639 F138S I139H A140S P141T S142F ... tiling clone,   639/639
(100 %)
4 diff
(99.4 %id)
CR604361 fetal brain .d 1 to 1270 1 to 1270 exact tiling clone,   1270/1270
(100 %)
0 diff
(100 %id)
BX445185 brain, fetal brain .d 193 to 1263 1056 to 1 K135X R137T G138R N139K E140X ...     1056/1110
(95 %)
43 diff
(96.2 %id)
AL536729 brain, fetal brain .d 342 to 1270 923 to 1 V114X Y115X N134X E140K V141A ...     923/923
(100 %)
18 diff
(98.1 %id)
BG054552 Kidney .d 749 to 1298 550 to 1   tiling clone,   550/550
(100 %)
0 diff
(100 %id)
BQ932034 leiomyosarcoma, uterus .e 1 to 891 23 to 931 D2T Q147P C154W tiling clone,   906/982
(92 %)
65 diff
(93.4 %id)
BP288836 lung .e 224 to 809 1 to 586       586/586
(100 %)
0 diff
(100 %id)
AA346933 heart .e 227 to 525 1 to 299       299/299
(100 %)
4 diff
(98.7 %id)
DA369935 subthalamic nucleus .e 227 to 800 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
AW961658   .e 228 to 854 1 to 628       628/628
(100 %)
8 diff
(98.8 %id)
DN990420 brain, whole brain .e 240 to 852 1 to 613       613/613
(100 %)
3 diff
(99.6 %id)
BX342244   .e 242 to 688 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
CN310764 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 254 to 830 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
CN310759 embryonic stem cells, DMSO-treated H9 cellline .e 255 to 630 1 to 376       376/376
(100 %)
1 diff
(99.8 %id)
CN310765 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 281 to 710 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BM673702.
matches multiple genes
eye, eye anterior segment .e 335 to 822 488 to 1     also hits gene mesuri 488/488
(100 %)
2 diff
(99.6 %id)
AU280004   .e 413 to 985 1 to 573   tiling clone,   573/573
(100 %)
0 diff
(100 %id)
BU949486.
matches multiple genes
Pancreas, Purified pancreatic islet .e 617 to 1154 9 to 546   tiling clone, also hits gene sesi 538/546
(98 %)
6 diff
(99.0 %id)
CA773710 Pancreas, Purified pancreatic islet .e 634 to 976 1 to 343       343/343
(100 %)
0 diff
(100 %id)
AW518887 adenocarcinoma, Pancreas .f 1 to 436 436 to 1 exact tiling clone,   436/436
(100 %)
1 diff
(99.8 %id)
N64316 cochlea, ear .g 1 to 447 447 to 1 exact tiling clone,   447/447
(100 %)
1 diff
(99.8 %id)
BP425886 small intestine .g 18 to 310 1 to 297     Submitted on the opposite strand 297/297
(100 %)
11 diff
(96.3 %id)
BX488870   .h 1 to 586 1 to 586   tiling clone,   586/586
(100 %)
0 diff
(100 %id)
BF857010 prostate_tumor .h 580 to 1004 424 to 1   tiling clone, Submitted on the opposite strand 424/435
(97 %)
14 diff
(96.8 %id)
CV424782 prostate_tumor .h 589 to 981 393 to 1   tiling clone, Submitted on the opposite strand 393/401
(98 %)
10 diff
(97.6 %id)
BF857012 prostate_tumor .h 612 to 1005 1 to 394       394/410
(96 %)
8 diff
(98.1 %id)
TI_149290431   .h 613 to 1420 878 to 85 exact AAA   794/796
(99 %)
15 diff
(98.2 %id)
N55216 multiple sclerosis lesions .h 660 to 1026 61 to 431       371/431
(86 %)
6 diff
(98.7 %id)
BM973428 lung .h 693 to 1420 740 to 19 exact tiling clone, AAA   722/722
(100 %)
7 diff
(99.1 %id)
AI680927 carcinoid, lung .h 804 to 1267 1 to 464 exact tiling clone, Submitted on the opposite strand 464/464
(100 %)
3 diff
(99.4 %id)
AI632886 carcinoid, lung .h 804 to 1266 1 to 463 exact   Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
BG149822 carcinoid, lung .h 804 to 1188 1 to 385     Submitted on the opposite strand 385/450
(85 %)
5 diff
(98.9 %id)
AI298620 carcinoid, lung .h 807 to 1232 1 to 426     Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
BX488871   .h 1294 to 1705 466 to 56   tiling clone, AAA   411/411
(100 %)
5 diff
(98.8 %id)
DA831482 placenta .i 1 to 318 2 to 320 exact tiling clone, fully sequenced, capped   319/319
(100 %)
0 diff
(100 %id)
DB377169 placenta .i 288 to 706 418 to 1   tiling clone, fully sequenced,   418/418
(100 %)
1 diff
(99.8 %id)
CB269416 adipose .j-u 1 to 366 1 to 365 H5L H6T I7Y P8H H9T ... tiling clone,   365/365
(100 %)
2 diff
(99.5 %id)
BX954967   .j-u 7 to 659 1 to 655   tiling clone,   655/655
(100 %)
1 diff
(99.9 %id)
CD236981 Pituitary .j-u 203 to 899 1 to 697   tiling clone,   697/697
(100 %)
2 diff
(99.8 %id)
AA321066 adipose tissue, brown .j-u 324 to 522 1 to 199       199/199
(100 %)
2 diff
(99.0 %id)
FN164571 breast carcinoma .j-u 728 to 808 1 to 82       82/82
(100 %)
4 diff
(95.2 %id)
H39858 breast .k 1 to 352 1 to 354 Y28I R29E S30V V31F Q32N ... tiling clone, fully sequenced,   354/354
(100 %)
5 diff
(98.6 %id)
AI610118 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k 5 to 619 614 to 1       614/622
(98 %)
15 diff
(97.6 %id)
AI769807 2 pooled tumors (clear cell type), Kidney .k 14 to 602 605 to 16       590/667
(88 %)
8 diff
(98.9 %id)
AW518894 adenocarcinoma, Pancreas .k 18 to 610 593 to 1   tiling clone,   593/593
(100 %)
1 diff
(99.9 %id)
R86213 breast .k 20 to 349 1 to 329       329/336
(97 %)
2 diff
(99.5 %id)
CA426663 cell lines, Chondrosarcoma .k 25 to 610 604 to 19   tiling clone, AAA   586/586
(100 %)
2 diff
(99.7 %id)
AW566008 fetal brain .k 28 to 610 1 to 579   tiling clone, AAA   579/579
(100 %)
3 diff
(99.5 %id)
BQ029845 lung, Metastatic Chondrosarcoma .k 83 to 610 546 to 19   AAA   528/528
(100 %)
2 diff
(99.7 %id)
H28050 breast .k 322 to 610 289 to 1   fully sequenced,   289/289
(100 %)
2 diff
(99.4 %id)
R62727 placenta Gene ANKRA2, variant not shown         This clone was ignored    
R63682 placenta Gene ANKRA2, variant not shown         This clone was ignored    
CD109981 Human Placenta, placenta Gene ANKRA2, variant not shown         Suspected internal deletion, this clone was ignored    
BP340466 Spleen Gene ANKRA2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_151699986   Gene ANKRA2, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f, .g, .h, .i, .j-u, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI